Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony S Floyd

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Recent Developments in Alcoholism : an Official Publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism|January 1, 2009
Facilitating involvement in twelve-step programsDennis M Donovan, Anthony S Floyd
Injury Epidemiology|March 8, 2021
Neighborhood disadvantage and firearm injury: does shooting location matter?Kimberly Dalve, Emma Gause, Brianna Mills, et al.
Substance Abuse and Rehabilitation|November 8, 2019
Opioid Use Disorder Treatment Decision Making And Care Navigation Upon Release From Prison: A Feasibility StudyCaleb J Banta-Green, Anthony S Floyd, Kristin Vick, et al.
The American Journal of Drug and Alcohol Abuse|August 23, 2011
How practice and science are balanced and blended in the NIDA Clinical Trials Network: the bidirectional process in the development of the STAGE-12 protocol as an exampleDennis M Donovan, Dennis C Daley, Gregory S Brigham, et al.
Injury Epidemiology|July 26, 2021
Barriers to recruitment, retention and intervention delivery in a randomized trial among patients with firearm injuriesAnthony S Floyd, Vivian H Lyons, Lauren K Whiteside, et al.
Substance Abuse and Rehabilitation|September 19, 2024
Community-Based Medications First for Opioid Use Disorder - Care Utilization and Mortality OutcomesCaleb J Banta-Green, Mandy D Owens, Jason R Williams, et al.
Substance Use & Addiction Journal|January 23, 2024
The Cost of Safe Injection: Insights on Nonprescription Syringe Price Variability From Systematic Secret ShoppingMalcolm J Blough, Amanda Rocha, Jeffrey Bratberg, et al.
Addiction Science & Clinical Practice|July 7, 2022
The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington StateCaleb J Banta-Green, Mandy D Owens, Jason R Williams, et al.
Journal of the American Pharmacists Association : Japha|October 20, 2023
Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chainsTraci C Green, Joseph Silcox, Derek Bolivar, et al.
Research in Social & Administrative Pharmacy : RSAP|February 23, 2024
"I go out of my way to give them an extra smile now:" A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materialsAdriane N Irwin, Mary Gray, Daniel Ventricelli, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Recent Developments in Alcoholism : an Official Publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism|January 1, 2009
Facilitating involvement in twelve-step programsDennis M Donovan, Anthony S Floyd
Injury Epidemiology|March 8, 2021
Neighborhood disadvantage and firearm injury: does shooting location matter?Kimberly Dalve, Emma Gause, Brianna Mills, et al.
Substance Abuse and Rehabilitation|November 8, 2019
Opioid Use Disorder Treatment Decision Making And Care Navigation Upon Release From Prison: A Feasibility StudyCaleb J Banta-Green, Anthony S Floyd, Kristin Vick, et al.
The American Journal of Drug and Alcohol Abuse|August 23, 2011
How practice and science are balanced and blended in the NIDA Clinical Trials Network: the bidirectional process in the development of the STAGE-12 protocol as an exampleDennis M Donovan, Dennis C Daley, Gregory S Brigham, et al.
Injury Epidemiology|July 26, 2021
Barriers to recruitment, retention and intervention delivery in a randomized trial among patients with firearm injuriesAnthony S Floyd, Vivian H Lyons, Lauren K Whiteside, et al.
Substance Abuse and Rehabilitation|September 19, 2024
Community-Based Medications First for Opioid Use Disorder - Care Utilization and Mortality OutcomesCaleb J Banta-Green, Mandy D Owens, Jason R Williams, et al.
Substance Use & Addiction Journal|January 23, 2024
The Cost of Safe Injection: Insights on Nonprescription Syringe Price Variability From Systematic Secret ShoppingMalcolm J Blough, Amanda Rocha, Jeffrey Bratberg, et al.
Addiction Science & Clinical Practice|July 7, 2022
The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington StateCaleb J Banta-Green, Mandy D Owens, Jason R Williams, et al.
Journal of the American Pharmacists Association : Japha|October 20, 2023
Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chainsTraci C Green, Joseph Silcox, Derek Bolivar, et al.
Research in Social & Administrative Pharmacy : RSAP|February 23, 2024
"I go out of my way to give them an extra smile now:" A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materialsAdriane N Irwin, Mary Gray, Daniel Ventricelli, et al.
Pageof 2